153 related articles for article (PubMed ID: 6165128)
1. Interaction of prolactin and testosterone in the human prostate.
Farnsworth WE; Slaunwhite WR; Sharma M; Oseko F; Brown JR; Gonder MJ; Cartagena R
Urol Res; 1981; 9(2):79-88. PubMed ID: 6165128
[TBL] [Abstract][Full Text] [Related]
2. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
Baranowska B; Zgliczyński S
Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
[TBL] [Abstract][Full Text] [Related]
3. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
Bard DR; Lasnitzki I
J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
[TBL] [Abstract][Full Text] [Related]
4. Measurements of prolactin and androgens in patients with prostatic diseases.
Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
Oncology; 1980; 37(1):46-52. PubMed ID: 6153126
[TBL] [Abstract][Full Text] [Related]
5. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
[TBL] [Abstract][Full Text] [Related]
6. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
Ghanadian R; Puah CM
J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
[TBL] [Abstract][Full Text] [Related]
7. Prolactin effect on the permeability of human benign hyperplastic prostate to testosterone.
Farnsworth WE
Prostate; 1988; 12(3):221-9. PubMed ID: 2453860
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
[TBL] [Abstract][Full Text] [Related]
9. Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
Geller J; Albert J; Geller S; Lopez D; Cantor T; Yen S
J Clin Endocrinol Metab; 1976 Nov; 43(5):1000-8. PubMed ID: 62759
[TBL] [Abstract][Full Text] [Related]
10. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
11. Androgen of the human prostate.
Farnsworth WE; Brown JR
Endocr Res Commun; 1976; 3(2):105-17. PubMed ID: 60232
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
[TBL] [Abstract][Full Text] [Related]
13. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN
BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
[TBL] [Abstract][Full Text] [Related]
14. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Habib FK; Lee IR; Stitch SR; Smith PH
J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
[TBL] [Abstract][Full Text] [Related]
15. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
Pejčić T; Tosti T; Tešić Ž; Milković B; Dragičević D; Kozomara M; Čekerevac M; Džamić Z
Prostate; 2017 Jul; 77(10):1082-1092. PubMed ID: 28594074
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
Yang Y; Chisholm GD; Habib FK
Br J Cancer; 1993 Jan; 67(1):152-5. PubMed ID: 7678977
[TBL] [Abstract][Full Text] [Related]
17. Prostate tissue androgens: history and current clinical relevance.
Marks LS; Mostaghel EA; Nelson PS
Urology; 2008 Aug; 72(2):247-54. PubMed ID: 18502483
[TBL] [Abstract][Full Text] [Related]
18. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
Smith CM; Ballard SA; Wyllie MG; Masters JR
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
[TBL] [Abstract][Full Text] [Related]
19. [Relation of prolactin with nodular hyperplasia and carcinoma of the prostate].
Romero L; Muñoz C; López A; Vilches J
Actas Urol Esp; 1991; 15(6):503-9. PubMed ID: 1724345
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
